PubMed

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.

Haney S, Hancox RJ.

Respir Res. 2007 Mar 6;8:19.PMID: 17341317 [PubMed - indexed for MEDLINE]Related articlesFree article

Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.

Haney S, Hancox RJ.

Respir Res. 2005 Sep 16;6:107.PMID: 16168062 [PubMed - indexed for MEDLINE]Related articlesFree article

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.

van der Woude HJ, Winter TH, Aalbers R.

Thorax. 2001 Jul;56(7):529-35.PMID: 11413351 [PubMed - indexed for MEDLINE]Related articlesFree article

Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.

Jonkers RE, Bantje TA, Aalbers R.

Respir Res. 2006 Dec 4;7:141.PMID: 17144916 [PubMed - indexed for MEDLINE]Related articlesFree article

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

Jones SL, Cowan JO, Flannery EM, Hancox RJ, Herbison GP, Taylor DR.

Eur Respir J. 2001 Mar;17(3):368-73.PMID: 11405513 [PubMed - indexed for MEDLINE]Related articlesFree article

Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.

Becker AB, Simons FE.

J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):891-5.PMID: 2574732 [PubMed - indexed for MEDLINE]Related articles

Tolerance to beta-agonists during acute bronchoconstriction.

Hancox RJ, Aldridge RE, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Town GI, Taylor DR.

Eur Respir J. 1999 Aug;14(2):283-7.PMID: 10515402 [PubMed - indexed for MEDLINE]Related articlesFree article

A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.

Lipworth BJ, Aziz I.

J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):88-92.PMID: 9893190 [PubMed - indexed for MEDLINE]Related articles

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.

Lanes SF, Garrett JE, Wentworth CE 3rd, Fitzgerald JM, Karpel JP.

Chest. 1998 Aug;114(2):365-72.PMID: 9726716 [PubMed - indexed for MEDLINE]Related articlesFree article

Formoterol: a review of its use in chronic obstructive pulmonary disease.

Cheer SM, Scott LJ.

Am J Respir Med. 2002;1(4):285-300. Review.PMID: 14720051 [PubMed - indexed for MEDLINE]Related articles

[Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]

Sprogøe-Jakobsen U, Viktrup L, Davidsen O, Viskum K.

Ugeskr Laeger. 1992 Nov 16;154(47):3325-8. Danish. PMID: 1361083 [PubMed - indexed for MEDLINE]Related articles

Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.

Garrett JE, Town GI, Rodwell P, Kelly AM.

J Allergy Clin Immunol. 1997 Aug;100(2):165-70.PMID: 9275135 [PubMed - indexed for MEDLINE]Related articles

Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.

McCrory DC, Brown CD.

Cochrane Database Syst Rev. 2001;(2):CD002984. Review.PMID: 11406052 [PubMed - indexed for MEDLINE]Related articles

Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.

Britton J, Hanley SP, Garrett HV, Hadfield JW, Tattersfield AE.

Thorax. 1988 Apr;43(4):300-5.PMID: 2970125 [PubMed - indexed for MEDLINE]Related articlesFree article

Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.

Lipworth BJ, Aziz I.

Chest. 2000 Jan;117(1):156-62.PMID: 10631214 [PubMed - indexed for MEDLINE]Related articlesFree article

Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?

Koutsogiannis Z, Kelly AM.

Aust N Z J Med. 2000 Feb;30(1):38-40.PMID: 10800876 [PubMed - indexed for MEDLINE]Related articles

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.

Yates DH, Kharitonov SA, Barnes PJ.

Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1603-7. Erratum in: Am J Respir Crit Care Med 1997 Apr;155(4):1491. PMID: 8970342 [PubMed - indexed for MEDLINE]Related articles

Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

Jarvis B, Markham A.

Drugs Aging. 2001;18(6):441-72. Review.PMID: 11419918 [PubMed - indexed for MEDLINE]Related articles

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.

Newnham DM, Grove A, McDevitt DG, Lipworth BJ.

Thorax. 1995 May;50(5):497-504.PMID: 7597661 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics.

Wong AG, O'Shaughnessy AD, Walker CM, Sears MR.

Eur Respir J. 1997 Feb;10(2):330-6.PMID: 9042628 [PubMed - indexed for MEDLINE]Related articlesFree article